UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (72) 72
life sciences & biomedicine (71) 71
humans (59) 59
cardiac & cardiovascular systems (57) 57
cardiovascular system & cardiology (57) 57
male (57) 57
female (48) 48
middle aged (45) 45
stents (40) 40
aged (38) 38
percutaneous coronary intervention (34) 34
cardiovascular (33) 33
treatment outcome (26) 26
transluminal angioplasty (22) 22
internal medicine (21) 21
coronary vessels (20) 20
coronary angiography (19) 19
time factors (18) 18
abridged index medicus (17) 17
cardiology (17) 17
heart attacks (16) 16
stent (16) 16
cardiology and cardiovascular medicine (15) 15
chronic total occlusion (15) 15
coronary heart disease (15) 15
risk factors (15) 15
angioplasty (14) 14
cardiovascular disease (14) 14
care and treatment (14) 14
implants (14) 14
myocardial infarction (14) 14
coronary angiography - methods (13) 13
general & internal medicine (13) 13
medicine, general & internal (12) 12
patients (12) 12
percutaneous coronary intervention - adverse effects (12) 12
chronic disease (11) 11
follow-up studies (11) 11
heart diseases (11) 11
surgical implants (11) 11
cardiac patients (10) 10
coronary artery (10) 10
coronary artery disease (10) 10
registries (10) 10
thrombosis (10) 10
adult (9) 9
clinical outcomes (9) 9
clinical trials (9) 9
coronary artery disease - mortality (9) 9
coronary occlusion - surgery (9) 9
mortality (9) 9
usage (9) 9
analysis (8) 8
coronary artery bypass (8) 8
coronary artery disease - diagnostic imaging (8) 8
coronary artery disease - therapy (8) 8
coronary vessels - surgery (8) 8
percutaneous coronary intervention - methods (8) 8
prospective studies (8) 8
coronary artery disease - surgery (7) 7
drug therapy (7) 7
drug-eluting stents (7) 7
electrocardiography (7) 7
europe (7) 7
lesions (7) 7
myocardial infarction - therapy (7) 7
outcomes (7) 7
percutaneous coronary intervention - instrumentation (7) 7
percutaneous coronary intervention - mortality (7) 7
platelet aggregation inhibitors - adverse effects (7) 7
retrospective studies (7) 7
stroke (7) 7
surgery (7) 7
veins & arteries (7) 7
acute coronary syndromes (6) 6
coronary flow reserve (6) 6
coronary occlusion - diagnostic imaging (6) 6
coronary vessels - diagnostic imaging (6) 6
diabetes (6) 6
echocardiography (6) 6
infarction (6) 6
ischemia (6) 6
medicine & public health (6) 6
myocardial infarction - diagnostic imaging (6) 6
occlusion (6) 6
platelet aggregation inhibitors - administration & dosage (6) 6
angioplasty, balloon, coronary - methods (5) 5
cardiovascular diseases (5) 5
cerebral infarction (5) 5
complications (5) 5
coronary circulation - physiology (5) 5
coronary occlusion - diagnosis (5) 5
coronary stenosis - diagnostic imaging (5) 5
coronary stent (5) 5
implantation (5) 5
laboratories (5) 5
prosthesis design (5) 5
radiation (5) 5
randomization (5) 5
risk assessment (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 805 - 815
Abstract Background The use of drug-eluting stents (DES) in patients at high risk of bleeding or thrombosis has not been prospectively studied; limited data... 
Cardiovascular | Internal Medicine | dual-antiplatelet therapy | high bleeding risk | high thrombotic risk | zotarolimus-eluting stent(s) | drug-eluting stent(s) | dualantiplatelet therapy | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Coronary Artery Disease - surgery | Humans | Immunosuppressive Agents - therapeutic use | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Coronary Restenosis - diagnosis | Coronary Angiography - methods | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Risk Assessment | Risk Factors | Coronary Restenosis - prevention & control | Treatment Outcome | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - diagnosis | Aged | Biocompatible Materials - therapeutic use | Percutaneous Coronary Intervention - adverse effects | Sects | Stent (Surgery) | Heart attacks | Drug therapy | Stents | Coronary vessels | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2016, Volume 316, Issue 22, pp. 2373 - 2384
Journal Article
The American journal of cardiology, ISSN 0002-9149, 2016, Volume 117, Issue 8, pp. 1267 - 1271
Journal Article
The New England journal of medicine, ISSN 1533-4406, 12/2016, Volume 375, Issue 23, pp. 2223 - 2235
Journal Article
PloS one, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, pp. e71902 - e71902
...Author(s): Margit Keresztes 1,*, Tamas Horvath 2, Imre Ocsovszki 1, Imre Foldesi 3, Gyongyi Serfozo 1, Krisztina Boda 4, Imre Ungi 2 Introduction Although... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Neutrophils - cytology | Coronary Artery Disease - surgery | Lewis X Antigen - blood | Humans | Middle Aged | Male | Biomarkers - blood | Coronary Artery Disease - blood | Acute Coronary Syndrome - blood | Angina, Stable - blood | Angina, Stable - surgery | Interleukin-6 - blood | Lactoferrin - blood | Acute Coronary Syndrome - surgery | Aged, 80 and over | Adult | Female | Aged | Hydrocortisone - blood | L-Selectin - blood | Stents | Adrenocorticotropic Hormone - blood | Percutaneous Coronary Intervention | Transluminal angioplasty | Medical research | Corticosteroids | Cardiac patients | Lactoferrins | Medicine, Experimental | ACTH | Angina pectoris | Risk factors | Stent (Surgery) | Steroids | Flow cytometry | Surgical implants | Heart attacks | Cardiovascular disease | Biochemistry | Hypothalamus | Hormones | Angina | Hydrocortisone | SAP protein | Interleukin 6 | Lactoferrin | Cell activation | Social interactions | Granulocytes | Rodents | Implants | Atherosclerosis | L-selectin | Cardiology | Heart diseases | Medical imaging | Cytokines | Neutrophils | Coronary artery | Health risks | Implantation | Hypothalamic-pituitary-adrenal axis | Leukocytes (neutrophilic) | Risk analysis | Coronary artery disease | Patients | Trauma | Cytometry | Adrenocorticotropic hormone | Pituitary | Coronary vessels | Diabetes | Acute coronary syndromes | Leukocytes (granulocytic) | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2015, Volume 65, Issue 8, pp. 777 - 786
Background The currently recommended duration of dual antiplatelet therapy (DAPT) in drug-eluting stent (DES) recipients is 12 months to reduce the risk of... 
double antiplatelet duration | percutaneous coronary angioplasty | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Postoperative Complications - prevention & control | Male | Hemorrhage - prevention & control | Aspirin - administration & dosage | Drug-Eluting Stents - adverse effects | Middle East | Early Termination of Clinical Trials | Coronary Restenosis - diagnosis | Coronary Artery Disease - physiopathology | Time Factors | Aspirin - adverse effects | Percutaneous Coronary Intervention - methods | Hemorrhage - etiology | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Female | Everolimus | Coronary Restenosis - etiology | Platelet Aggregation Inhibitors - adverse effects | Coronary Vessels - pathology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Europe | Coronary Restenosis - prevention & control | Treatment Outcome | Coronary Artery Disease - mortality | Postoperative Complications - diagnosis | Ticlopidine - analogs & derivatives | Coronary Artery Disease - therapy | Coronary Artery Disease - diagnosis | Coronary Vessels - surgery | Aged | Percutaneous Coronary Intervention - adverse effects | Aspirin | Index Medicus | Abridged Index Medicus
Journal Article
by Sibbing, Dirk and Aradi, Dániel and Jacobshagen, Claudius and Gross, Lisa and Trenk, Dietmar and Geisler, Tobias and Orban, Martin and Hadamitzky, Martin and Merkely, Béla and Kiss, Róbert Gábor and Komócsi, András and Dézsi, Csaba A and Holdt, Lesca and Felix, Stephan B and Parma, Radoslaw and Klopotowski, Mariusz and Schwinger, Robert H G and Rieber, Johannes and Huber, Kurt and Neumann, Franz-Josef and Koltowski, Lukasz and Mehilli, Julinda and Huczek, Zenon and Massberg, Steffen and Parma, Zofia and Lesiak, Maciej and Komosa, Anna and Kowara, Michal and Rymuza, Bartosz and Malek, Lukasz and Aradi, Daniel and Veress, Gábor and Dézsi, András Döme and Lux, Árpád and Papp, Judit and Kovács, Andrea and Dézsi, Csaba András and Amer, Sayour and Ruzsa, Zoltán and Róna, Szilárd and Ili, Renáta and Ungi, Imre and Nagy, Ferenc and Zweiker, Robert and Tóth-Gayor, Gábor and Haller, Paul and von Scheidt, Wolfgang and Blüthgen, Andreas and Leggewie, Stefan and Kreider-Stempfle, Hans Ulrich and Remp, Thomas and Kara, Kaffer and Mügge, Andreas and Wutzler, Alexander and Fichtlscherer, Stephan and Zeiher, Andreas M and Seeger, Florian and Hinterseer, Martin and König, Andreas and Lederle, Susanne and Czepluch, Frauke and Maier, Lars and Schillinger, Wolfgang and Sossalla, Samuel and Hummel, Astrid and Felix, Stephan and Karakas, Mahir and Sydow, Karsten and Rudolph, Tanja and Halbach, Marcel and Gori, Tommaso and Münzel, Thomas and May, Andreas and Gerstenberg, Carsten-Manuel and Pilecky, David and Deichstetter, Markus and Kääb, Stefan and Löw, Anja and Orban, Matthias and Sattler, Stefan and Deuschl, Sabine and Teupser, Daniel and Mudra, Harald and Räder, Thomas and Schütz, Torsten and Vahldiek, Felix and Divchev, Dimitar and Ince, Hüseyin and Nienaber, Christoph A and Radunski, Henning and Boekstegers, Peter and Horstkotte, Jan and Mueller, Ralf and Müller, Karin and Schwinger, Robert and Rasp, Oliver and TROPICAL-ACS Investigators
The Lancet (British edition), ISSN 0140-6736, 10/2017, Volume 390, Issue 10104, pp. 1747 - 1757
Current guidelines recommend potent platelet inhibition with prasugrel or ticagrelor for 12 months after an acute coronary syndrome managed with percutaneous... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Myocardial Infarction - epidemiology | Acute Coronary Syndrome - epidemiology | Drug Administration Schedule | Hemorrhage - epidemiology | Humans | Middle Aged | Europe - epidemiology | Male | Prasugrel Hydrochloride - adverse effects | Ticlopidine - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Platelet Function Tests | Ticlopidine - adverse effects | Ticlopidine - administration & dosage | Acute Coronary Syndrome - therapy | Clopidogrel | Female | Stroke - epidemiology | Hemorrhage - chemically induced | Prasugrel Hydrochloride - administration & dosage | Drug Monitoring | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Transluminal angioplasty | Care and treatment | Coronary heart disease | Cardiac patients | Analysis | Anticoagulants | Heart attacks | Blood platelets | Angioplasty | Clinical trials | Acute coronary syndromes | Drug therapy | Patients | Evidence-based medicine | Clinical outcomes | Myocardial infarction | Intervention | Bleeding | Consortia | Randomization | Motivation | Inhibition | Cerebral infarction | Stroke | Test procedures | Health risks | Thrombosis | Coronary vessels | Biomarkers | Infarction | Cardiovascular diseases | Platelets | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2019, Volume 381, Issue 19, pp. 1820 - 1830
Journal Article